321 related articles for article (PubMed ID: 11305380)
41. Hodgkin's lymphoma in a patient of psoriasis treated with long-term, low-dose methotrexate therapy.
Khopkar U; Bhor U
Indian J Dermatol Venereol Leprol; 2008; 74(4):379-82. PubMed ID: 18797063
[TBL] [Abstract][Full Text] [Related]
42. Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy.
Rattanakaemakorn P; Pinyowiwat P; Iamsumang W; Chanprapaph K; Suchonwanit P
Drug Des Devel Ther; 2021; 15():2299-2307. PubMed ID: 34093007
[TBL] [Abstract][Full Text] [Related]
43. Clinical efficacy of platelet rich plasma in combination with methotrexate in chronic plaque psoriatic patients.
Chakravdhanula U; Anbarasu K; Verma VK; Beevi SS
Dermatol Ther; 2016 Nov; 29(6):446-450. PubMed ID: 27418241
[TBL] [Abstract][Full Text] [Related]
44. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
Jeffes EW; Weinstein GD
Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
[TBL] [Abstract][Full Text] [Related]
45. [Guidelines on the use of methotrexate in psoriasis].
Carretero G; Puig L; Dehesa L; Carrascosa JM; Ribera M; Sánchez-Regaña M; Daudén E; Vidal D; Alsina M; Muñoz-Santos C; López-Estebaranz JL; Notario J; Ferrandiz C; Vanaclocha F; García-Bustinduy M; Taberner R; Belinchón I; Sánchez-Carazo J; Moreno JC;
Actas Dermosifiliogr; 2010 Sep; 101(7):600-13. PubMed ID: 20858386
[TBL] [Abstract][Full Text] [Related]
46. Dermatologists' adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey.
Berends MA; de Jong EM; van de Kerkhof PC; Gerritsen MJ
Dermatology; 2007; 215(1):45-52. PubMed ID: 17587839
[TBL] [Abstract][Full Text] [Related]
47. Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine.
Opmeer BC; Heydendael VM; De Borgie CA; Spuls PI; Bossuyt PM; Bos JD; De Rie MA
Arch Dermatol; 2004 Jun; 140(6):685-90. PubMed ID: 15210458
[TBL] [Abstract][Full Text] [Related]
48. Lung function in children and adolescents with juvenile idiopathic arthritis during long-term treatment with methotrexate: a retrospective study.
Leiskau C; Thon A; Gappa M; Dressler F
Clin Exp Rheumatol; 2012; 30(2):302-7. PubMed ID: 22409955
[TBL] [Abstract][Full Text] [Related]
49. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
de Jong EM; Mørk NJ; Seijger MM; De La Brassine M; Lauharanta J; Jansen CT; Guilhou JJ; Guillot B; Ostrojic A; Souteyrand P; Vaillant L; Barnes L; Rogers S; Klaber MR; Van De Kerkhof PC
Br J Dermatol; 2003 Feb; 148(2):318-25. PubMed ID: 12588386
[TBL] [Abstract][Full Text] [Related]
50. Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.
Inzinger M; Weger W; Heschl B; Salmhofer W; Quehenberger F; Wolf P
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):861-6. PubMed ID: 22672248
[TBL] [Abstract][Full Text] [Related]
51. Liver biopsies from psoriatics related to methotrexate therapy. 2. Findings before and after methotexate therapy in 88 patients. A blind study.
Nyfors A; Poulsen H
Acta Pathol Microbiol Scand A; 1976 May; 84(3):262-70. PubMed ID: 1274591
[TBL] [Abstract][Full Text] [Related]
52. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
53. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
[TBL] [Abstract][Full Text] [Related]
54. Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting.
Raaby L; Zachariae C; Østensen M; Heickendorff L; Thielsen P; Grønbæk H; Skov L; Kyvsgaard N; Madsen JT; Heidenheim M; Funding AT; Strauss G; Lindberg R; Iversen L
Acta Derm Venereol; 2017 Apr; 97(4):426-432. PubMed ID: 27958611
[TBL] [Abstract][Full Text] [Related]
55. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
[TBL] [Abstract][Full Text] [Related]
56. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
[TBL] [Abstract][Full Text] [Related]
57. Methotrexate for psoriasis.
Boffa MJ; Chalmers RJ
Clin Exp Dermatol; 1996 Nov; 21(6):399-408. PubMed ID: 9167333
[TBL] [Abstract][Full Text] [Related]
58. The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children.
Rahman SI; Siegfried E; Flanagan KH; Armbrecht ES
J Am Acad Dermatol; 2014 Feb; 70(2):252-6. PubMed ID: 24332314
[TBL] [Abstract][Full Text] [Related]
59. [Weekly low-dose methotrexate in rheumatoid arthritis. Review of the literature].
Manganelli P; Troise Rioda W
Minerva Med; 1993 Oct; 84(10):541-52. PubMed ID: 8247309
[TBL] [Abstract][Full Text] [Related]
60. Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis.
Yamauchi PS; Lowe NJ
Int J Dermatol; 2008 Feb; 47(2):202-4. PubMed ID: 18211500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
